AKT1S1 and neurofibromatosis: Abnormal PRAS40 activation and high levels of phospho-PRAS40 have been indicated as putative biomarkers in melanoma, prostate cancer, and NSCLC [48], but the role of PRAS40 in MPNST or neurofibromatosis has yet to be explored.